Head of section Mr. Beyer, head of the Key technologies at the BMFTR, visited the LPI in Jena in November and gained up close insights and demonstrations for selected LPI basic technologies. The LPI gGmbH and representatives of the partner institutions illustrated the progresses and emphasized the need of the LPI infrastructure in Jena.
LPI gGmbH
9 posts
The LPI was represented at this year's MEDICA in Dusseldorf. At the joint booth of the Free State of Thuringia organized by the LEG Thüringen, the LPI made an appearance as as translational center for photonic innovations.
Around 100 researchers of our partner institutions discussed current advances in imaging diagnostics, biological models and computational analytics.
At the DGHM 2025 in Jena scientists of the executing institutions represented the LPI with multiple poster contributions.
At the spring meeting around 100 researchers from the partner institutions discussed current advances in imaging diagnostics, biological models and AI-supported analytics.
The LPI basic technology projects had their 6th project meeting on 15 November 2024. Scientists from all partners presented their project progress.
A delegation from the German Federal Ministry of Education and Research (BMBF) visited the InfectoGnostics Research Campus Jena and the LPI on Thursday.
BMBF State Secretary Prof. Sabine Döring and Thuringian Economics Minister Wolfgang Tiefensee visited the Leibniz Centre for Photonics in Infection Research on 7 November 2023.
With the founding of LPI gGmbH on 25.04.2024, the Leibniz Centre for Photonics in Infection Research is entering the next era. The four consortium partners of the new centre - the Leibniz Institute of Photonic Technology (Leibniz IPHT), the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz HKI), the Friedrich Schiller University Jena (FSU) and the University Hospital Jena (UKJ) - have thus taken the decisive step to consolidate the LPI as a globally unique translational infrastructure - as a bridge from research to application. LPI gGmbH will be established as an open-user one-stop agency. It combines all services, technologies and competences under one roof that are required to significantly accelerate the development and transfer of market-ready light-based diagnostic procedures and novel therapeutic approaches for the treatment of infectious diseases.